1
|
Gurnani B, Christy J, Kaur K, Moutappa F, Gubert J. Successful Management of Pythium insidiosum Keratitis Masquerading as Dematiaceous Fungal Keratitis in an Immunosuppressed Asian Male. Ocul Immunol Inflamm 2024; 32:583-586. [PMID: 36812410 DOI: 10.1080/09273948.2023.2179495] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2021] [Revised: 02/06/2023] [Accepted: 02/07/2023] [Indexed: 02/24/2023]
Abstract
PURPOSE To describe the first case of Pythium insidiosum keratitis masquerading as dematiaceous fungal keratitis in a seropositive male. CASE SUMMARY A 44-year-old seropositive male previously treated for acute retinal necrosis presented with pain and defective vision in the right eye following a mud injury 5 days back. Presenting visual acuity was hand movements close to the face. Ocular examination revealed a 7 × 7 mm dense, greyish-white mid stromal infiltrate with pigmentation and few tentacles. The clinical diagnosis suggested fungal keratitis. Corneal scraping on 10% KOH and Gram stain revealed slender, aseptate hyaline hyphae. Before culture results, the patient was treated with topical 5% natamycin and 1% voriconazole, but the infiltrate progressed. Culture on 5% sheep blood agar revealed white fluffy, submerged, shiny, and appressed colonies, and Pythium insidiosum was confirmed by zoospore formation. The patient was further managed with topical linezolid 0.2% hourly, azithromycin 1% hourly, and adjuvant drugs. CONCLUSION This is an uncommon presentation of Pythium keratitis masquerading as dematiaceous fungal keratitis in an immunocompromised male.
Collapse
Affiliation(s)
- Bharat Gurnani
- Consultant Cataract, Cornea and Refractive Services, Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Pondicherry, India
- Sadguru Chikitsa Netralaya, Shri Sadguru Seva Sangh Trust, Chitrakoot, Madhya Pradesh, India
| | - Josephine Christy
- Consultant Cataract, Cornea and Refractive Services, Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Pondicherry, India
| | - Kirandeep Kaur
- Consultant Cataract, Pediatric Ophthalmology and Strabismus, Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Pondicherry, India
- Sadguru Chikitsa Netralaya, Shri Sadguru Seva Sangh Trust, Chitrakoot, Madhya Pradesh, India
| | - Fredrick Moutappa
- Consultant Cataract, Pediatric Ophthalmology and Strabismus, Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Pondicherry, India
| | - Joseph Gubert
- Consultant Department of Microbiology, Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Pondicherry, India
| |
Collapse
|
2
|
Warnnissorn P, Sawatdiwithayayong J, Surit P. Efficacy and Rapidity of Potassium Hydroxide Mount and Modified Chicago Sky Blue 6B Stain with Potassium Hydroxide in Fungal Keratitis Detection. KOREAN JOURNAL OF OPHTHALMOLOGY 2024; 38:98-104. [PMID: 38351488 PMCID: PMC11016681 DOI: 10.3341/kjo.2023.0106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2023] [Revised: 12/22/2023] [Accepted: 01/20/2024] [Indexed: 04/16/2024] Open
Abstract
PURPOSE To compare the efficacy and rapidity of direct microscopic detection of fungal elements from corneal ulcers between 10% potassium hydroxide (KOH) and 1% Chicago Sky Blue 6B (CSB) in 10% KOH (CSB-KOH). METHODS Thirty patients with clinically suspected fungal keratitis were recruited. Participants with impending corneal perforation were excluded. Two slides were smeared with corneal ulcer scrapings from the ulcer's edge and base for comparison of fungal staining solutions. One slide was infused with KOH, and the other slide was filled with CSB-KOH. Additional scraping was collected for inoculation on Sabouraud dextrose agar for fungal culture. The sensitivity, specificity and rapidity of both stainings were analyzed. RESULTS The sensitivity of fungal culture, KOH, and CSB-KOH were 43.75% (95% confidence interval [CI], 19.75%-70.12%), 62.50% (95% CI, 35.43%-84.80%), and 87.50% (95% CI, 61.65%-98.45%), respectively. The specificity were 100% (95% CI, 69.15%-100%) of both stainings and fungal culture which analyzed from 16 fungal keratitis cases by laboratory and clinical diagnosis. Mean CSB-KOH examination time was quicker than KOH with the mean time difference of 5.6 minutes (95% CI, 3.22-7.98 minutes) and p-value < 0.001. CONCLUSIONS CSB-KOH was more effective and faster than KOH in detecting fungal elements from corneal ulcers. Therefore, CSB-KOH may be beneficial in diagnosing fungal keratitis and preventing blindness. Moreover, to the best of our knowledge, this is the first use of CSB stain in fungal keratitis detection.
Collapse
Affiliation(s)
- Prateep Warnnissorn
- Department of Medicine, Faculty of Medicine, Naresuan University, Phitsanulok,
Thailand
| | | | - Phrutthinun Surit
- Department of Biochemistry, Faculty of Medical Science, Naresuan University, Phitsanulok,
Thailand
| |
Collapse
|
3
|
Loreto ES, Tondolo JSM, Zanette RA. Treating Pythiosis with Antibacterial Drugs Targeting Protein Synthesis: An Overview. J Fungi (Basel) 2024; 10:234. [PMID: 38667905 PMCID: PMC11051233 DOI: 10.3390/jof10040234] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2024] [Revised: 03/08/2024] [Accepted: 03/18/2024] [Indexed: 04/28/2024] Open
Abstract
This review article explores the effectiveness of antibacterial drugs that inhibit protein synthesis in treating pythiosis, a difficult-to-treat infection caused by Pythium insidiosum. The article highlights the susceptibility of P. insidiosum to antibacterial drugs, such as macrolides, oxazolidinones, and tetracyclines. We examine various studies, including in vitro tests, experimental infection models, and clinical case reports. Based on our synthesis of these findings, we highlight the potential of these drugs in managing pythiosis, primarily when combined with surgical interventions. The review emphasizes the need for personalized treatment strategies and further research to establish standardized testing protocols and optimize therapeutic approaches.
Collapse
Affiliation(s)
- Erico S. Loreto
- Sobresp Faculty of Health Sciences, 520 Appel Street, Santa Maria 97015-030, RS, Brazil;
| | - Juliana S. M. Tondolo
- Sobresp Faculty of Health Sciences, 520 Appel Street, Santa Maria 97015-030, RS, Brazil;
| | - Régis A. Zanette
- Department of Pharmacology, Basic Health Sciences Institute, Federal University of Rio Grande do Sul, 2600 Ramiro Barcelos Street, Porto Alegre 90035-003, RS, Brazil;
| |
Collapse
|
4
|
Gurnani B, Natarajan R, Mohan M, Kaur K. Breaking-Down Barriers: Proposal of Using Cellulose Biosynthesis Inhibitors and Cellulase Enzyme as a Novel Treatment Modality for Vision Threatening Pythium Insidiosum Keratitis. Clin Ophthalmol 2024; 18:765-776. [PMID: 38495678 PMCID: PMC10941664 DOI: 10.2147/opth.s450665] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2023] [Accepted: 03/05/2024] [Indexed: 03/19/2024] Open
Abstract
Pythium insidiosum, an Oomycete, causes severe keratitis that endangers vision. Its clinical, morphological, and microbiological characteristics are often indistinguishable from those of fungal keratitis, earning it the moniker "parafungus". Distinctive clinical hallmarks that set it apart from other forms of keratitis include radial keratoneuritis, tentacles, marginal infiltration, and a propensity for rapid limbal spread. The therapeutic approach to Pythium keratitis (PK) has long been a subject of debate, and topical and systemic antifungals and antibacterials have been tried with limited success. Approximately 80% of these eyes undergo therapeutic keratoplasty to salvage the eye. Hence, there is a need to innovate for alternative and better medical therapy to safeguard these eyes. The resistance of Pythium to standard antifungal treatments can be attributed to the absence of ergosterol in its cell wall. Cell walls of plants and algae have cellulose as an essential constituent. Cellulose imparts strength and structure and acts as the "skeleton" of the plant. Fungal and animal cell walls typically lack cellulose. The cellular architecture of Pythium shares a similarity with plant and algal cells through the incorporation of cellulose within its cell wall structure. Inhibitors targeting cellulose biosynthesis (CBI), such as Indaziflam, Isoxaben, and Quinoxyphen, serve as critical tools for elucidating the pathways of cellulose synthesis. Furthermore, the enzymatic action of cellulase is instrumental for the extraction of proteins and DNA. To circumvent this issue, we hypothesize that CBI's and cellulase enzymes can act on the Pythium cell wall and may effectively treat PK. The available literature supporting the hypothesis and proof of concept has also been discussed. We have also discussed these drugs' molecular mechanism of action on the Pythium cell wall. We also aim to propose how these drugs can be procured and used as a potential medical management option for this devastating entity.
Collapse
Affiliation(s)
- Bharat Gurnani
- Department of Cataract, Cornea and Refractive Surgery, ASG Eye Hospital, Jodhpur, Rajasthan, 342008, India
| | - Radhika Natarajan
- Department of Cornea and Refractive Surgery, Sankara Nethralaya Medical Research Foundation, Chennai, Tamil Nadu, 600006, India
| | - Madhuvanthi Mohan
- Department of Cornea and Refractive Surgery, Sankara Nethralaya Medical Research Foundation, Chennai, Tamil Nadu, 600006, India
| | - Kirandeep Kaur
- Department of Pediatric Ophthalmology and Strabismus, ASG Eye Hospital, Jodhpur, Rajasthan, 342008, India
| |
Collapse
|
5
|
Gurnani B, Kaur K, Tandon A. Letter Regarding: Randomized Double-Masked Placebo-Controlled Trial for the Management of Pythium Keratitis: Combination of Antibiotics Versus Monotherapy. Cornea 2023; 42:e22-e23. [PMID: 37487172 DOI: 10.1097/ico.0000000000003350] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/26/2023]
Affiliation(s)
- Bharat Gurnani
- Cataract, Cornea, Refractive Services, Trauma, External Diseases, and Ocular Surface, Sadguru Netra Chikitsalya, Shri Sadguru Seva Sangh Trust, Janaki Kund, Chitrakoot, Madhya Pradesh, India
| | - Kirandeep Kaur
- Children Eye Care Centre, Pediatric Ophthalmology and Strabismus, Sadguru Netra Chikitsalya, Shri Sadguru Seva Sangh Trust, Janaki Kund, Chitrakoot, Madhya Pradesh, India
| | - Astha Tandon
- Cornea and Refractive Services, Sadguru Netra Chikitsalya, Shri Sadguru Seva Sangh Trust, Janaki Kund,, Chitrakoot, Madhya Pradesh, India
| |
Collapse
|
6
|
Pippi B, Loreto ES, Merkel S, Joaquim AR, Krummenauer ME, Reginatto P, Vainstein MH, Andrade SF, Fuentefria AM, Santurio JM, Zanette RA. Pythium insidiosum: insights into biofilm formation and antibiofilm activity of antifungal drugs. Braz J Microbiol 2023; 54:2603-2607. [PMID: 37702922 PMCID: PMC10689302 DOI: 10.1007/s42770-023-01123-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2023] [Accepted: 09/05/2023] [Indexed: 09/14/2023] Open
Abstract
In this study, we investigate the ability of Pythium insidiosum to form biofilms across various substrates and the antibiofilm efficacy of 8-hydroxyquinoline derivatives (8-HQs). Biofilms of P. insidiosum were cultured on polystyrene plates, contact lenses, and horsehair. We provide the first evidence of P. insidiosum's biofilm-forming capability, thus considerably expanding our understanding of its transmission and pathogenesis. Our results demonstrate that 8-HQs effectively inhibit biofilm formation and eradicate pre-existing biofilms, underscoring their potential as a novel treatment strategy for pythiosis, a disease currently lacking a gold-standard treatment. This finding has particular relevance for ocular pythiosis associated with contact lens usage and potential infection sources in animals. Our results contribute to the scientific knowledge base and directly impact innovative therapeutic interventions' development.
Collapse
Affiliation(s)
- B Pippi
- Graduation Program in Pharmacology, Federal University of Santa Maria, Santa Maria, RS, Brazil
| | - E S Loreto
- Sobresp Faculty of Health Sciences, Santa Maria, RS, Brazil
| | - S Merkel
- Graduation Program in Biological Sciences: Pharmacology and Therapeutics, Department of Pharmacology, Basic Health Sciences Institute, Federal University of Rio Grande Do Sul, 2600 Ramiro Barcelos Street, Porto Alegre, RS, 90035-003, Brazil
| | - A R Joaquim
- Graduation Program in Pharmaceutical Sciences, Federal University of Rio Grande Do Sul, Porto Alegre, RS, Brazil
| | - M E Krummenauer
- Biotechnology Center, Federal University of Rio Grande Do Sul, Porto Alegre, RS, Brazil
| | - P Reginatto
- Graduation Program in Pharmaceutical Sciences, Federal University of Rio Grande Do Sul, Porto Alegre, RS, Brazil
| | - M H Vainstein
- Biotechnology Center, Federal University of Rio Grande Do Sul, Porto Alegre, RS, Brazil
| | - S F Andrade
- Graduation Program in Pharmaceutical Sciences, Federal University of Rio Grande Do Sul, Porto Alegre, RS, Brazil
| | - A M Fuentefria
- Graduation Program in Biological Sciences: Pharmacology and Therapeutics, Department of Pharmacology, Basic Health Sciences Institute, Federal University of Rio Grande Do Sul, 2600 Ramiro Barcelos Street, Porto Alegre, RS, 90035-003, Brazil
- Graduation Program in Pharmaceutical Sciences, Federal University of Rio Grande Do Sul, Porto Alegre, RS, Brazil
| | - J M Santurio
- Graduation Program in Pharmacology, Federal University of Santa Maria, Santa Maria, RS, Brazil
| | - R A Zanette
- Graduation Program in Biological Sciences: Pharmacology and Therapeutics, Department of Pharmacology, Basic Health Sciences Institute, Federal University of Rio Grande Do Sul, 2600 Ramiro Barcelos Street, Porto Alegre, RS, 90035-003, Brazil.
| |
Collapse
|
7
|
Gurnani B, Kaur K. Understanding barriers, recommended solutions, and future prospects for the diagnosis and management of Pythium insidiosum keratitis. Indian J Ophthalmol 2023; 71:3584-3586. [PMID: 37991287 PMCID: PMC10788758 DOI: 10.4103/ijo.ijo_1041_23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2023] [Revised: 07/31/2023] [Accepted: 08/04/2023] [Indexed: 11/23/2023] Open
Abstract
Pythium insidiosum keratitis (PIK) is a devastating corneal infection resulting in blindness in a large number of cases. Clinically and morphologically, it closely mimics fungal keratitis, and hence is also labeled as "parafungus." Although many clinical studies have documented evidence regarding the virulence of microorganism, and anatomical and functional outcomes, it remains a clinical challenge and diagnostic dilemma for most clinicians. Till today, PIK is being diagnosed and treated with certainty at only limited centers across the globe. But the question is why this is so? Taking this as the research question, this section on current ophthalmology aims to highlight the understanding of barriers to diagnosing and treating PIK, the suggestions to improve diagnosis and treatment, and the future prospects.
Collapse
Affiliation(s)
- Bharat Gurnani
- Cataract, Cornea, Trauma, External Disease, Ocular Surface and Refractive Services, Sadguru Netra Chikitsalya, Shri Sadguru Seva Sangh Trust, Chitrakoot, Madhya Pradesh, India
| | - Kirandeep Kaur
- Cataract, Pediatrics Ophthalmology and Strabismus Services, Sadguru Netra Chikitsalya, Shri Sadguru Seva Sangh Trust, Chitrakoot, Madhya Pradesh, India
| |
Collapse
|
8
|
Gurnani B, Kaur K. Leap forward in clinical and photographic diagnosis of Pythium insidiosum keratitis. Indian J Ophthalmol 2023; 71:3263-3264. [PMID: 37602622 PMCID: PMC10565910 DOI: 10.4103/ijo.ijo_355_23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/22/2023] Open
Affiliation(s)
- Bharat Gurnani
- Consultant Cataract, Cornea, External Diseases, Trauma, Ocular Surface and Refractive Services, Janaki-Kund, Chitrakoot, Madhya Pradesh, India
| | - Kirandeep Kaur
- Consultant Cataract, Pediatric Ophthalmology and Strabismus, Sadguru Netra Chikitsalya, Shri Sadguru Seva Sangh Trust, Janaki-Kund, Chitrakoot, Madhya Pradesh, India
| |
Collapse
|
9
|
Gurnani B, Kaur K. Predicting Prognosis Based on Regional Prevalence, Ulcer Morphology and Treatment Strategy in Vision-Threatening Pythium insidiosum Keratitis. Clin Ophthalmol 2023; 17:1307-1314. [PMID: 37181081 PMCID: PMC10167989 DOI: 10.2147/opth.s412274] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2023] [Accepted: 04/24/2023] [Indexed: 05/16/2023] Open
Abstract
Pythium insidiosum is an oomycete belonging to the phylum Straminipila and family Pythiaceae. It causes rapidly progressive vision-threatening keratitis. Clinically, microbiologically and morphologically, it closely resembles fungal keratitis; hence it is also labelled as a "parafungus". The clinical features mimicking fungus are subepithelial and stromal infiltrate, endo-exudates, corneal melt and hypopyon. The hallmark features of Pythium are tentacular projections, reticular dot-like infiltrate, peripheral furrowing and thinning, and rapid limbal spread. Microbiological corneal smearing on KOH and Gram stain reveal septate or aseptate, obtuse to perpendicular hyphae which mimic fungal hyphae. Culture on any nutritional agar reveals cream, cottonwool-like, fluffy colonies, and diagnosis is confirmed by zoospore formation by the leaf incarnation method. Medical management with antifungals and antibacterials still presents a dilemma. Early therapeutic keratoplasty has been the proposed treatment in most cases. We hypothesize that the prognosis of Pythium keratitis is governed by regional geographical variations, ulcer size and density on presentation, and initial treatment strategy. The available literature supporting the proposed hypothesis is also discussed, along with the hallmark features of Pythium and how it masquerades as other microorganisms causing keratitis. We also aim to propose a novel diagnostic and treatment algorithm for managing this vision-threatening keratitis.
Collapse
Affiliation(s)
- Bharat Gurnani
- Department of Cornea and Refractive Surgery, Sadguru Netra Chikitsalya, Shri Sadguru Seva Sangh Trust, Chitrakoot, Madhya Pradesh, 485334, India
| | - Kirandeep Kaur
- Department of Pediatric Ophthalmology, Sadguru Netra Chikitsalya, Shri Sadguru Seva Sangh Trust, Chitrakoot, Madhya Pradesh, 485334, India
| |
Collapse
|
10
|
Gurnani B, Kaur K, Kumar T. Commentary: Current concepts, recent updates, and future treatment options for Pythium insidiosum keratitis. Indian J Ophthalmol 2023; 71:1874-1876. [PMID: 37203047 PMCID: PMC10391502 DOI: 10.4103/ijo.ijo_80_23] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/20/2023] Open
Affiliation(s)
- Bharat Gurnani
- Departments of Cataract, Cornea, Trauma, External Disease, Ocular Surface and Refractive Services, Sadguru Netra Chikitsalya, Shri Sadguru Seva Sangh Trust, Janaki Kund, Chitrakoot, Madhya Pradesh, India
| | - Kirandeep Kaur
- Department of Cataract, Pediatric Ophthalmology and Strabismus Services, Sadguru Netra Chikitsalya, Shri Sadguru Seva Sangh Trust, Janaki Kund, Chitrakoot, Madhya Pradesh, India
| | - Tathagata Kumar
- Department of Optometry, Dr. Om Parkash Eye, Institute, Amritsar, Punjab, India
| |
Collapse
|
11
|
Cao B, Gonugunta VT, Radhakrishnan N, Lalitha P, Gurnani B, Kaur K, Iyer G, Agarwal S, Srinivasan B, Keenan JD, Prajna NV. Outcomes of Pythium keratitis: a meta-analysis of individual patient data. CURRENT OPHTHALMOLOGY REPORTS 2022; 10:198-208. [PMID: 37250102 PMCID: PMC10211475 DOI: 10.1007/s40135-022-00302-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/24/2022] [Indexed: 11/11/2022]
Abstract
Background Pythium keratitis is a difficult-to-treat corneal infection. Methods A meta-analysis of individual patient data from observational studies of Pythium keratitis was performed. The outcomes of interest were therapeutic penetrating keratoplasty (TPK) and globe removal (evisceration, enucleation, or exenteration); the main exposures were linezolid and azithromycin use. Findings Of 46 eligible articles, individual patient data were available for 306 eyes (34 studies). Pythium keratitis was associated with high rates of TPK (80%, 95%CI 70-87%) and globe removal (25%, 95%CI 13-43). In multivariable models adjusting for age and country, fewer TPKs were performed in patients treated with azithromycin (RR=0.80, 95%CI 0.67-0.96; P=0.04) and linezolid (RR=0.82, 95%CI 0.67-0.99; P=0.02). Conclusions Studies of Pythium keratitis reported high rates of TPK and globe removal. Use of azithromycin and linezolid was associated with a lower rate of TPK. While promising, these results should be interpreted with caution given the biases inherent to observational studies.
Collapse
Affiliation(s)
- Binh Cao
- Francis I Proctor Foundation, University of California, San Francisco, USA
| | | | - Naveen Radhakrishnan
- Department of Cornea and Refractive Surgery, Aravind Eye Hospital Madurai, India
| | - Prajna Lalitha
- Department of Ocular Microbiology, Aravind Eye Hospital Madurai, India
| | - Bharat Gurnani
- Dr. Om Parkash Eye Institute, Amritsar, India
- Aravind Eye Hospital and Post Graduate Institute, Pondicherry, India
| | - Kirandeep Kaur
- Dr. Om Parkash Eye Institute, Amritsar, India
- Aravind Eye Hospital and Post Graduate Institute, Pondicherry, India
| | - Geetha Iyer
- C J Shah Cornea Services, Dr G Sitalakshmi Memorial Clinic for Ocular Surface Disorders, Sankara Nethralaya, Chennai, India
| | - Shweta Agarwal
- C J Shah Cornea Services, Dr G Sitalakshmi Memorial Clinic for Ocular Surface Disorders, Sankara Nethralaya, Chennai, India
| | - Bhaskar Srinivasan
- C J Shah Cornea Services, Dr G Sitalakshmi Memorial Clinic for Ocular Surface Disorders, Sankara Nethralaya, Chennai, India
| | - Jeremy D Keenan
- Francis I Proctor Foundation, University of California, San Francisco, USA
- Department of Ophthalmology, University of California, San Francisco, USA
| | - N Venkatesh Prajna
- Department of Cornea and Refractive Surgery, Aravind Eye Hospital Madurai, India
| |
Collapse
|